Past Trials

• 01 Jan `21Brandon, FL USAEvaluate the efficacy and safety of investigational medication
    Official title: A Phase III, randomized, double blind, placebo controlled study to evaluate the efficacy and safety of AS012 in subjects with nonsegmental vitiligo Ages eligible: 18 + years of age Stipend: Receive compensation for your time a...
• 25 Sep `20Worcester, University of Massachusetts, MA, USAStudy to Evaluate RECELL and MKTP for Repigmentation of Stable Vitiligo Lesions
    Official Title: Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions In Brief: Prospective randomized within-subject controlled feasibility study to evaluate t...
• 20 Nov `19Tunis, TUNISIAEvaluation of the Efficacy of a Dermocosmetic Product
  Official Title: Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo In Brief: Comparative study, Lithium liposome  versus placebo in intra-individual study. Ages Eligible: 18 Ye...
• 03 Oct `19Multicenter, USAIncyte: Ruxolitinib cream (TRuE-V2)
  Official Title: Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) In Brief: The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adolescent and adult participants with non-segmental vitiligo for whom...
• 25 Sep `19Worcester, USADermavant Sciences: Cerdulatinib Gel
  Official Title: A Phase 2a, Randomized, Double-Blind, Vehicle-Controlled Study to Assess the Safety, Tolerability, and Systemic Exposure of Cerdulatinib Gel, 0.37% in Adults With Vitiligo.  In Brief: Cerdulatinib 0.37% gel applied topically twice...
• 20 Sep `19Multicenter, USAIncyte: Ruxolitinib cream (TRuE-V1)
  Official Title: Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1): A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period in Participants With Vitiligo. I...
• 17 Jun `19Nice, FRANCEGlisodin with UVB
  Official Title: Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo. A Randomized Double Blind Placebo Controlled Monocentric Study In Brief: Glisodin 4 pills a day (1000mg) for 3 months then 2 pi...
• 30 May `19Chicago, USAGut and Skin Microbiome
  Official Title: The Gut and Skin Microbiome in Vitiligo Disease Progression In Brief: Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare ...
• 26 Nov `18USA, CANADA, BELGIUM, GERMANY, JAPAN, KOREA, SPAIN, TAIWANPfizer: PF-06651600 and PF-06700841
  Official Title: A Phase 2B randomized, double-blind, placebo-controlled, multicenter, dose-ranging study to evaluate the efficacy and safety profile of PF-06651600 with a partially blinded extension period to evaluate efficacy and safety of PF-066...
• 01 Nov `18Cairo, EGYPTSkin Color in Stabilization of Vitiligo by UVB
  Official Title: Contribution of Skin Color in Stabilization of Active Cases of Vitiligo by Narrow Band UVB In Brief: Vitiligo is a disease in which autoimmunity plays a major role. Multiple treatment options are available, of which narrow-band UV...
• 18 Sep `18Xi'an, CHINAGut Microbiome and Metabolic Pathways
  Official Title: The Gut Microbiome and Metabolic Activity in Patients With Vitiligo In Brief: Vitiligo is a chronic depigmenting autoimmune-associated skin disease and a growing psychological health concern because of its low quality of life. Gen...
• 30 Aug `18Yonsei, REPUBLIC OF KOREAInvestigation on the Expression of HMGB1
  Official Title: The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity In Brief: Vitiligo is an...
• 13 Apr `18Porto Alegre, BRAZILSurgical Treatment of Vitiligo
  Official Title: Comparative Study of Surgical Treatment of Vitiligo: Microneedling Versus Microneedling With Suspension of Uncultured Epidermal Cells In Brief: A comparative study for the surgical treatment of vitiligo in which the same patient w...
• 19 Mar `18multicenter, USAAclaris Therapeutics: Topical Solution
  Official title: An Open-Label Pilot Study of the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily in Adult Subjects With Non-Segmental Facial Vitiligo In brief: This is a multicenter, open-label study desig...
• 18 Mar `18USAAclaris Therapeutics: ATI-50002
  Official Title: A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo In Brief: The main objective of this study is to assess the safety, tolerability and efficacy of ATI-50002 Topical Solution, 0.46% in subjects with non-segmental ...
• 01 Jan `18Xi'an, CHINAEffects of Camouflage on the Life Quality
  Official Title: Development and Psychometric Validation of the Chinese Version of Vitiligo Life Quality Index and Effects of Camouflage on the Life Quality of Patients With Vitiligo: A Randomized Open-label Controlled Study In Brief: Vitiligo is ...
• 11 Aug `17Bydgoszcz, POLANDSimvastatin And Atorvastatin Effect On Vitiligo
  Official Title: The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo (EVRAAS) In Brief: The aim of this study is to evaluate th...
• 01 Jul `17Chandigarh, INDIAComparison of Surgical Methods
  Official Title: A Comparative Study Between Autologous Mini Punch Grafting, Suction Blister Grafting and Non-Cutured Epidermal Cell Suspension on Resistant Sites in Stable Vitiligo In Brief: Comparing the Efficacy of Three Different Surgical Meth...
• 21 Apr `17New York, USACelgene: Apremilast with NB-UVB
  Official title: A Split Body Study of the Effects of Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo. Phase II In brief: Procedure: Each participant will be compared with one side of th...
• 04 Apr `17Multicenter, USAIncyte: A Study of Ruxolitinib 1,5% cream
  Official Title: A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo In Brief: The purpose of this study will be to examine the efficacy, safety, and tolerability of ruxolitinib cream in subjects with vitiligo. Description: Ruxolitini...
• 30 Jan `16Multicenter, USAIncyte: Topical Ruxolitinib for the Treatment of Vitiligo
  Official Title: Topical Ruxolitinib for the Treatment of Vitiligo In Brief: The purpose of this study is to determine if topical ruxolitinib 1.5% will provide repigmentation in vitiligo lesions. Description: The hypothesis is that JAK inhibitors...
• 21 Jan `16Nice, FRANCEEfficacy of Micro-holes
  Official Title: Comparison of the Efficacy of Micro-holes vs. Laser-assisted Dermabrasion, for Repigmenting in Vitiligo Skin In Brief: The principal objective is to compare the efficacy of laser-assisted dermabrasion + autologous epidermal cells ...